N-cadherin as an invasion promoter

A novel target for antitumor therapy?

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Cell adhesion molecules of the cadherin superfamily are frequently altered during tumor progression. The loss of E-cadherin, in particular, has long been described in various epithelial cancers where it correlates with malignancy and metastasis. In addition, a subset of tumors show de novo expression or upregulation of N-cadherin, a cadherin that promotes cell motility and invasion. In spite of the accumulating evidence supporting the relationship between N-cadherin levels and cancer progression, the causal role of N-cadherin in tumor development has not yet been clearly demonstrated. This review will address this issue at three different levels: (i) the Eqression pattern of N-cadherin in cancer, (ii) the cellular events that are modulated by N-cadherin and could account for its pro-invasive role in tumorigenesis; and (iii) the signaling properties of N-cadherin, with particular emphasis on its cross-talk with cell surface partners such as fibroblast growth factor receptor and with intracellular cascades such as the anti-apoptotic machinery. Taken together, the topics discussed in this review point to N-cadherin as an important player in tumor development and, therefore, a potential target for novel therapeutic approaches.

Original languageEnglish
Pages (from-to)1274-1278
Number of pages5
JournalCurrent Opinion in Investigational Drugs
Volume5
Issue number12
Publication statusPublished - Dec 2004

Fingerprint

Cadherins
Neoplasms
Therapeutics
Fibroblast Growth Factor Receptors
Cell Adhesion Molecules
Cell Movement
Carcinogenesis
Up-Regulation
Neoplasm Metastasis

Keywords

  • Cadherin switch
  • Cell survival
  • Cell-cell adhesion
  • FGFR signaling
  • Invasion
  • N-cadherin
  • Tumor microenvironment

ASJC Scopus subject areas

  • Pharmacology

Cite this

N-cadherin as an invasion promoter : A novel target for antitumor therapy? / Cavallaro, Ugo.

In: Current Opinion in Investigational Drugs, Vol. 5, No. 12, 12.2004, p. 1274-1278.

Research output: Contribution to journalArticle

@article{c8c4dab31fa14a749ab998f62fe4c2a9,
title = "N-cadherin as an invasion promoter: A novel target for antitumor therapy?",
abstract = "Cell adhesion molecules of the cadherin superfamily are frequently altered during tumor progression. The loss of E-cadherin, in particular, has long been described in various epithelial cancers where it correlates with malignancy and metastasis. In addition, a subset of tumors show de novo expression or upregulation of N-cadherin, a cadherin that promotes cell motility and invasion. In spite of the accumulating evidence supporting the relationship between N-cadherin levels and cancer progression, the causal role of N-cadherin in tumor development has not yet been clearly demonstrated. This review will address this issue at three different levels: (i) the Eqression pattern of N-cadherin in cancer, (ii) the cellular events that are modulated by N-cadherin and could account for its pro-invasive role in tumorigenesis; and (iii) the signaling properties of N-cadherin, with particular emphasis on its cross-talk with cell surface partners such as fibroblast growth factor receptor and with intracellular cascades such as the anti-apoptotic machinery. Taken together, the topics discussed in this review point to N-cadherin as an important player in tumor development and, therefore, a potential target for novel therapeutic approaches.",
keywords = "Cadherin switch, Cell survival, Cell-cell adhesion, FGFR signaling, Invasion, N-cadherin, Tumor microenvironment",
author = "Ugo Cavallaro",
year = "2004",
month = "12",
language = "English",
volume = "5",
pages = "1274--1278",
journal = "Current Opinion in Investigational Drugs",
issn = "1472-4472",
publisher = "Current Drugs Ltd.",
number = "12",

}

TY - JOUR

T1 - N-cadherin as an invasion promoter

T2 - A novel target for antitumor therapy?

AU - Cavallaro, Ugo

PY - 2004/12

Y1 - 2004/12

N2 - Cell adhesion molecules of the cadherin superfamily are frequently altered during tumor progression. The loss of E-cadherin, in particular, has long been described in various epithelial cancers where it correlates with malignancy and metastasis. In addition, a subset of tumors show de novo expression or upregulation of N-cadherin, a cadherin that promotes cell motility and invasion. In spite of the accumulating evidence supporting the relationship between N-cadherin levels and cancer progression, the causal role of N-cadherin in tumor development has not yet been clearly demonstrated. This review will address this issue at three different levels: (i) the Eqression pattern of N-cadherin in cancer, (ii) the cellular events that are modulated by N-cadherin and could account for its pro-invasive role in tumorigenesis; and (iii) the signaling properties of N-cadherin, with particular emphasis on its cross-talk with cell surface partners such as fibroblast growth factor receptor and with intracellular cascades such as the anti-apoptotic machinery. Taken together, the topics discussed in this review point to N-cadherin as an important player in tumor development and, therefore, a potential target for novel therapeutic approaches.

AB - Cell adhesion molecules of the cadherin superfamily are frequently altered during tumor progression. The loss of E-cadherin, in particular, has long been described in various epithelial cancers where it correlates with malignancy and metastasis. In addition, a subset of tumors show de novo expression or upregulation of N-cadherin, a cadherin that promotes cell motility and invasion. In spite of the accumulating evidence supporting the relationship between N-cadherin levels and cancer progression, the causal role of N-cadherin in tumor development has not yet been clearly demonstrated. This review will address this issue at three different levels: (i) the Eqression pattern of N-cadherin in cancer, (ii) the cellular events that are modulated by N-cadherin and could account for its pro-invasive role in tumorigenesis; and (iii) the signaling properties of N-cadherin, with particular emphasis on its cross-talk with cell surface partners such as fibroblast growth factor receptor and with intracellular cascades such as the anti-apoptotic machinery. Taken together, the topics discussed in this review point to N-cadherin as an important player in tumor development and, therefore, a potential target for novel therapeutic approaches.

KW - Cadherin switch

KW - Cell survival

KW - Cell-cell adhesion

KW - FGFR signaling

KW - Invasion

KW - N-cadherin

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=11344267384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11344267384&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 1274

EP - 1278

JO - Current Opinion in Investigational Drugs

JF - Current Opinion in Investigational Drugs

SN - 1472-4472

IS - 12

ER -